• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Leo Pharma’s Tralokinumab News: What You Need to Know

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 20, 2021 at 11:12: PM
via Will Leo Pharma’s Adtralza® (tralokinumab) get its U.S. Food and Drug Administration (FDA) approval this year? While there’s no confirmation yet, the pharmaceutical company has already received a Positive CHMP Opinion for the treatment.

article source
 




Top Bottom
Back
Quote